The generated NKG2D CAR-T demonstrated potent cytotoxicity against glioblastoma cell lines in vitro, which is consistent with a recent report that NKG2D CAR-T is effective against glioblastoma (10). This evidence concerns the gene KLRK1 and glioblastoma.